{
  "ticker": "RPRX",
  "success": true,
  "price": {
    "current": 40.86,
    "currency": "USD",
    "day_high": 40.91,
    "day_low": 40.375,
    "52_week_high": 41.7,
    "52_week_low": 29.66
  },
  "market_cap": {
    "value": 23828500480.0,
    "currency": "USD"
  },
  "shares_outstanding": 427247489.0,
  "volume": {
    "last": 2906310,
    "average_30d": 3744624
  },
  "valuation": {
    "pe_ratio": 23.348572,
    "forward_pe": 8.105358,
    "price_to_book": 2.7329276
  },
  "company_info": {
    "name": "Royalty Pharma plc",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 19347280000.0,
    "total_liabilities": 9726419000.0,
    "stockholders_equity": 6414348000.0,
    "cash": 938944000.0,
    "marketable_securities": 876173000.0,
    "total_liquidity": 1815117000.0,
    "total_debt": 8945735000.0,
    "long_term_debt": 8565735000.0,
    "current_debt": 380000000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": 702615000.0,
    "free_cash_flow": 702615000.0,
    "investing_cash_flow": -958314000.0,
    "financing_cash_flow": 562735000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 182135000.0,
    "research_and_development": 50500000.0,
    "interest_expense": 79564000.0,
    "net_income": 288217000.0,
    "revenue": 609291000.0,
    "gross_profit": null,
    "ebitda": 525052000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:51:19.116047",
    "url": "https://finance.yahoo.com/quote/RPRX",
    "data_hash": "8b53db5c6e1de8fe"
  }
}